8-((4-chlorophenyl)thio)cyclic-3--5--gmp and Hypertrophy

8-((4-chlorophenyl)thio)cyclic-3--5--gmp has been researched along with Hypertrophy* in 1 studies

Other Studies

1 other study(ies) available for 8-((4-chlorophenyl)thio)cyclic-3--5--gmp and Hypertrophy

Article	Year
Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling. Journal of cellular physiology, 2019, Volume: 234, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides	2019

Article

Year

Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling.

Journal of cellular physiology, 2019, Volume: 234, Issue:10

Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides

2019